BrightSpring Health Services (BTSG) Cash & Equivalents (2023 - 2026)

BrightSpring Health Services (BTSG) has reported Cash & Equivalents for 4 consecutive years, with $550.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents rose 685.47% year-over-year to $550.4 million; the trailing twelve-month figure through Jun 2026 stood at $550.4 million (up 685.47% YoY), and the FY2025 full-year result was $88.4 million, up 44.98% from the prior year.
• Cash & Equivalents fell to $550.4 million in Q2 2026 per BTSG's latest filing, from $888.8 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $888.8 million in Q1 2026 and bottomed at $13.1 million in Q4 2023.
• Historically, Cash & Equivalents has averaged $180.3 million across 4 years, with a median of $61.0 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Cash & Equivalents dropped 9.82% in 2025, then soared 1598.22% in 2026.
• Over 4 years, Cash & Equivalents stood at $13.1 million in 2023, then jumped by 366.33% to $61.0 million in 2024, then surged by 44.98% to $88.4 million in 2025, then soared by 522.81% to $550.4 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $550.4 million, $888.8 million, and $88.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.